1,956
Views
52
CrossRef citations to date
0
Altmetric
Original Article

Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study

, , , , , , , , , , & show all
Pages 576-586 | Received 05 Apr 2018, Accepted 06 Sep 2018, Published online: 25 Oct 2018

References

  • Lind M, García Rodríguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia. 2013;56:2601–2608.
  • Tinsley LJ, Kupelian V, D’Eon SA, et al. Association of glycemic control with reduced risk for large-vessel disease after more than 50 years of type 1 diabetes. J Clin Endocrinol Metab. 2017;102:3704–3711.
  • Paneni F, Lüscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Cardiol. 2017;120:S17–S27.
  • Borg R, Kuenen JC, Carstensen B, et al. HbA1. (HbA1(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2011;54:69–72.
  • Cavagnolli G, Pimentel AL, Freitas PA, et al. Factors affecting A1C in non-diabetic individuals: review and meta-analysis. Clin Chim Acta. 2015;445:107–114.
  • McCarter RJ, Hempe JM, Gomez R, et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27:1259–1264.
  • Angoorani P, Heshmat R, Ejtahed HS, et al. Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eat Weight Disord. 2018. DOI: 10.1007/s40519-018-0488-z
  • Irace C, Carallo C, Scavelli FB, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013; 67:665–672.
  • Sanchez-Inigo L, Navarro-Gonzalez D, Fernandez-Montero A, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189–197.
  • Hempe JM, Gomez R, McCarter RJ, Jr, et al. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313–320.
  • Hempe JM, Liu S, Myers L, et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Dia Care. 2015;38:1067–1074.
  • Ahn CH, Min SH, Lee DH, et al. Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism. J Clin Endocrinol Metab. 2017;102:2905–2913.
  • Xiang K, Ji L, Xiang H, et al. Diagnosis and management of the metabolic syndrome: A Chinese Diabetes Society Scientific Statement. Chin J Diabetes. 2004; 12:156–161.
  • Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.
  • Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–3351.
  • Dash DK, Choudhury AK, Singh M, et al. Effect of parental history of diabetes on markers of inflammation, insulin resistance and atherosclerosis in first degree relatives of patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2018;12:12:285–289.
  • Kim MK, Ahn CW, Kang S, et al. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16:108.
  • Vega GL, Barlow CE, Grundy SM, et al. Triglyceride-to-high-density- lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62:345–349.
  • Nayak AU, Nevill AM, Bassett P, et al. Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care. 2013;36:3247–3253.
  • Rodriguez-Segade S, Rodriguez J, Cabezas-Agricola JM, et al. Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (HbA1c). Clin Chem. 2011;57:264–271.
  • Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28:2013–2018.
  • Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167:1068–1074.
  • Ren Y, Ren Q, Lu J, et al. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: a cross-sectional survey in China. Diabetes Metab Res Rev 2018;34. DOI:10.1002/dmrr.2960
  • Budoff M. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease. Am J Cardiol. 2016;118:138–145.
  • Tenenbaum A, Klempfner R, Fisman EZ. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol. 2014;13:159.
  • Farhangkhoee H, Khan ZA, Barbin Y, et al. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia. 2005;48:1401–1410.
  • Zhou SX, Huo DM, He XY, et al. High glucose/lysophosphatidylcholine levels stimulate extracellular matrix deposition in diabetic nephropathy via platelet activating factor receptor. Mol Med Rep 2018;17:2366–2372.
  • Liu S, Hempe JM, McCarter RJ, et al. Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults. J Clin Endocrinol Metab. 2015;100:2364–2371.
  • Van Steen SC, Woodward M, Chalmers J, et al. Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia. 2018;61:780–789.
  • Rainwater DL. Lipoprotein correlates of LDL particle size. Atherosclerosis. 2000;148:151–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.